Device
High Flow Nasal Therapy
High Flow Nasal Therapy is a medical device with 6 clinical trials. Historical success rate of 100.0%.
Total Trials
6
Max Phase
—
Type
DEVICE
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 4 completed trials
Completion Rate
100%(4/4)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Phase Distribution
Ph not_applicable
5
83%
Phase Distribution
0
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution5 total trials
N/ANon-phased studies
5(100.0%)
Highest Phase Reached
UnknownTrial Status & Enrollment
Completion Rate
100.0%
4 of 4 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
6
all time
Status Distribution
Completed(4)
Other(2)
Detailed Status
Completed4
unknown2
Development Timeline
Analytics
Development Status
Total Trials
6
Active
0
Success Rate
100.0%
Most Advanced
N/A
Trials by Phase
N/A5 (100.0%)
Trials by Status
unknown233%
completed467%
Recent Activity
0 active trials
Showing 5 of 6
completednot_applicable
Nasal Oxygen Therapy After Cardiac Surgery
NCT05308719
completednot_applicable
High-Flow Aerosol Generation Study
NCT05384275
unknownnot_applicable
High VS Low Flow Nasal O2 for Acute Hypercapnic Respiratory Failure
NCT04640948
unknown
High Flow Nasal Therapy in Covid 19 Patient
NCT05094648
completednot_applicable
HFNT vs. COT in COVID-19
NCT04655638
Clinical Trials (6)
Showing 6 of 6 trials
NCT05308719Not Applicable
Nasal Oxygen Therapy After Cardiac Surgery
NCT05384275Not Applicable
High-Flow Aerosol Generation Study
NCT04640948Not Applicable
High VS Low Flow Nasal O2 for Acute Hypercapnic Respiratory Failure
NCT05094648
High Flow Nasal Therapy in Covid 19 Patient
NCT04655638Not Applicable
HFNT vs. COT in COVID-19
NCT04350970Not Applicable
High-flow Nasal Cannula and Exercise Tolerance in COPD
All 6 trials loaded
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 6